PLK2 and colorectal carcinoma: p53 dependent PLK2 interacts with TSC1/2 to amplify their suppressive effect on mTOR; Loss of PLK2 function promotes CRC and NSCLC progression (99, 100); and MSI-H specific frameshift mutation may be the internal cause of PLK2 dysfunction (107).